Da: Chiron Media, Wallingford, Regno Unito
EUR 89,15
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: New.
Condizione: NEW.
Da: Majestic Books, Hounslow, Regno Unito
EUR 145,30
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New. New/New Author: Qamar, ImteyazEdition: 1ISBN-13: 9780323904612Release Date: 01-06-2022Package Dimensions: 90 x 60 x 06 inchesLanguages: EnglishBinding: paperback<b.
Da: Revaluation Books, Exeter, Regno Unito
EUR 148,10
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 300 pages. 9.00x6.00x0.63 inches. In Stock.
Condizione: New. 1st edition NO-PA16APR2015-KAP.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 148,60
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 165,11
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Elsevier Science & Technology, 2022
ISBN 10: 0323904610 ISBN 13: 9780323904612
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 161,79
Quantità: Più di 20 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 129,16
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Elsevier Science & Technology Jun 2022, 2022
ISBN 10: 0323904610 ISBN 13: 9780323904612
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 144,00
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-Oncology: From Basic Research to Advanced Study analyzes the emerging the field of cardio-oncology, reviewing recent advancements in the field, discussing how to monitor and treat cancer survivors for cardiotoxicity, and identifying potential cardiac side effects in novel cancer therapies. By adopting a translational approach, the book first comprehensively covers the basic science, mechanisms and concepts, which is followed by advanced state-of-art of cardio-oncology. Other sections cover tyrosine kinase inhibitors, Anthracyclines, and biomarkers in cardiotoxicity induced by chemotherapeutic drugs, noninvasive cardiovascular imaging techniques, radiotherapy induced cardiovascular, and more. Anti-cancer treatment is associated with serious cardiovascular adverse events, including arterial and pulmonary hypertension, supraventricular and ventricular arrhythmias, systolic and diastolic cardiac dysfunction and coronary artery disease. Progress in cancer therapy over the past decades improved long-term survival but increased cancer therapy-related cardiotoxicity. Both traditional chemotherapeutic agents and newer therapies have demonstrated profound cardiovascular toxicities. It is important to understand the mechanisms of these toxicities to establish strategies for the prevention and management of complications-arrhythmias, heart failure, and even death. 276 pp. Englisch.
Da: moluna, Greven, Germania
EUR 141,87
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Adopts a translational approach and comprehensively covers the basic science, mechanisms and concepts of cardio-oncology Outlines the current knowledge of biomarkers in cancer therapy-related cardiotoxicity Provides an understandi.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 157,99
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-Oncology: From Basic Research to Advanced Study analyzes the emerging the field of cardio-oncology, reviewing recent advancements in the field, discussing how to monitor and treat cancer survivors for cardiotoxicity, and identifying potential cardiac side effects in novel cancer therapies. By adopting a translational approach, the book first comprehensively covers the basic science, mechanisms and concepts, which is followed by advanced state-of-art of cardio-oncology. Other sections cover tyrosine kinase inhibitors, Anthracyclines, and biomarkers in cardiotoxicity induced by chemotherapeutic drugs, noninvasive cardiovascular imaging techniques, radiotherapy induced cardiovascular, and more. Anti-cancer treatment is associated with serious cardiovascular adverse events, including arterial and pulmonary hypertension, supraventricular and ventricular arrhythmias, systolic and diastolic cardiac dysfunction and coronary artery disease. Progress in cancer therapy over the past decades improved long-term survival but increased cancer therapy-related cardiotoxicity. Both traditional chemotherapeutic agents and newer therapies have demonstrated profound cardiovascular toxicities. It is important to understand the mechanisms of these toxicities to establish strategies for the prevention and management of complications-arrhythmias, heart failure, and even death.